Role of surgical resection for multiple hepatocellular carcinomas (Q36561656)

14 August 2017

Role of surgical resection for multiple hepatocellular carcinomas (English)

1 reference

14 August 2017

Sung Hoon Choi

1

1 reference

14 August 2017

Gi Hong Choi

2

1 reference

14 August 2017

Seung Up Kim

3

1 reference

14 August 2017

Jun Yong Park

4

1 reference

14 August 2017

Dong Jin Joo

5

1 reference

14 August 2017

Man Ki Ju

6

1 reference

14 August 2017

Myoung Soo Kim

7

1 reference

14 August 2017

Jin Sub Choi

8

1 reference

14 August 2017

Kwang Hyub Han

9

1 reference

14 August 2017

Soon Il Kim

10

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

19

1 reference

14 August 2017

3

1 reference

14 August 2017

366-374

1 reference

Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Clonal origin of multifocal hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Cirrhosis: CT and MR imaging evaluation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Management of hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Resection prior to liver transplantation for hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Comparison of Clinicopathologic Characteristics and Outcomes After Resection in Patients With Hepatocellular Carcinoma Treated in the United States, France, and Japan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Surgical treatment of hepatocellular carcinoma in cirrhosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Liver resection improves the survival of patients with multiple hepatocellular carcinomas

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Transarterial chemoembolization in patients not eligible for liver transplantation: single-center results.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Liver resection for hepatocellular carcinoma in patients with cirrhosis.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554821

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

21 October 2018

1 reference

12 December 2020

Simplified staging for hepatocellular carcinoma

1 reference

12 December 2020

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

1 reference

12 December 2020

Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for Transplantation

1 reference

12 December 2020

The prognosis of patients with hepatocellular carcinoma of multicentric origin

1 reference

12 December 2020

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths

1 reference

12 December 2020

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

1 reference

12 December 2020

Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database

1 reference

12 December 2020

Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Pathophysiology of portal hypertension in HCV-related cirrhosis. Putative role of assessment of portal pressure gradient in Peginterferon-treated patients

1 reference

12 December 2020

Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?

1 reference

12 December 2020

Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?

1 reference

12 December 2020

Resection and liver transplantation for HCC

1 reference

12 December 2020

Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV

1 reference

12 December 2020

Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria

1 reference

12 December 2020

Chemoembolization for unresectable hepatocellular carcinoma in Japan

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V19.I3.366

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23372359

1 reference